LeonMBSmithCRMackM, et al.
Transcatheter aortic-valve implantation for aortic stenosis in patients who cannot undergo surgery. N Engl J Med2010;
363: 1597–607.
2.
MackMJLeonMBSmithCR, et al.
5-year outcomes of transcatheter aortic valve replacement or surgical aortic valve replacement for high surgical risk patients with aortic stenosis (PARTNER 1): a randomised controlled trial. Lancet2015;
385: 2477–2484.
3.
LeonMBSmithCRMackMJ, et al.; PARTNER 2 Investigators.
Transcatheter or surgical aortic-valve replacement in intermediate risk patients.N Engl J Med2016;
374: 1609–1620.
4.
ThouraniVHKodaliSMakkarRR, et al.
Transcatheter aortic valve replacement versus surgical valve replacement in intermediate-risk patients: a propensity score analysis. Lancet2016;
387: 2218–2225.
5.
ReardonMJVan MieghemNMPopmaJJ, et al; SURTAVI Investigators.
Surgical or transcatheter aortic-valve replacement in intermediate-risk patients.N Engl J Med2017;
376: 1321–1331.
6.
MackMJLeonMBThouraniVH, et al;
PARTNER 3 Investigators. Transcatheter aortic-valve replacement with a balloon-expandable valve in low-risk patients. N Engl J Med2019;
380: 1695–1705.
7.
PopmaJJDeebGMYakubovSJ, et al; Evolut Low Risk Trial Investigators.
Transcatheter aortic-valve replacement with a self-expanding valve in low-risk patients.N Engl J Med2019;
380: 1706–1715.
8.
NishimuraRAOttoCMBonowRO, et al.
2017 AHA/ACC focused update of the 2014 AHA/ACC guideline for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Task Force on clinical practice guidelines.J Am Coll Cardiol2017;
70: 252–289.
9.
OttoCMNishimuraRABonowRO, et al.
2020 ACC/AHA guideline for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines.Circulation2021;
143:e72–e227. Erratum in: Circulation 2021; 143: e229.
10.
AdamsDHPopmaJJReardonMJ, et al.
Transcatheter aortic-valve replacement with a self-expanding prosthesis. N Engl J Med2014;
370: 1790–1798.
11.
DeebGMReardonMJChetcutiS, et al.
3-Year outcomes in high-risk patients who underwent surgical or transcatheter aortic valve replacement. J Am Coll Cardiol2016;
67: 2565–2574.
12.
The writing group of The Latinamerican Association of Cardiac & Endovascular Surgery: The Latinamerican Association of Cardiac & Endovascular Surgery Statement regarding the recently released AHA/ACC Guidelines for the Management of Patients with Valvular Heart Disease 2020. Asian Cardiovasc Thorac Ann2021; (in press).
13.
IzumiCEishiKAshiharaK, et al:
JCS/JSCS/JATS/JSVS 2020 guidelines on the management of valvular heart disease.Circ J2020;
84: 2037–2119
14.
StoneGWLindenfeldJAbrahamWT, et al; COAPT Investigators.
Transcatheter mitral-valve repair in patients with heart failure. N Engl J Med2018;
379: 2307–2318.
15.
ObadiaJFMessika-ZeitounDLeurentG, et al; MITRA-FR Investigators.
Percutaneous repair or medical treatment for secondary mitral regurgitation.N Engl J Med2018;
379: 2297–2306.
16.
Messika-ZeitounDIungBArmoiryX, et al.
Impact of mitral regurgitation severity and left ventricular remodeling on outcome after mitraclip implantation: results from the Mitra-FR trial. JACC Cardiovasc Imaging2020 Sep 16: S1936-878X(20)30645-8. doi: 10.1016/j.jcmg.2020.07.021. Epub ahead of print.
17.
MauriLFosterEGlowerDD, et al;
EVEREST II Investigators. 4-year results of a randomized controlled trial of percutaneous repair versus surgery for mitral regurgitation. J Am Coll Cardiol2013;
62: 317–328.
18.
SwaansMJBakkerALMAlipourA, et al.
Survival of transcatheter mitral valve repair compared with surgical and conservative treatment in high-surgical-risk patients. JACC Cardiovasc Interv2014;
7: 875–881.
19.
GoldsteinDMoskowitzAJGelijnsAC, et al; CTSN.
Two-year outcomes of surgical treatment of severe ischemic mitral regurgitation. N Engl J Med2016;
374: 344–353.
